Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PABPC1 | P11940 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29557391 | 1.00 | PABPC1 (0.56) | PABPC1ALDH1A1HPGDKDM4EMAPT | |
| SCHEMBL28008858 | 0.81 | ALDH1A1 (0.51) | PABPC1ALDH1A1HPGDKDM4EMAPT | |
| SCHEMBL2025750 | 0.81 | PABPC1 (0.49) | PABPC1ALDH1A1HPGDKDM4EMAPT | |
| SCHEMBL2837800 | 0.77 | ALDH1A1 (0.58) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL6443558 | 0.77 | PABPC1 (0.46) | PABPC1ALDH1A1HPGDKDM4EMAPT | |
| SCHEMBL17054695 | 0.76 | HPRT1 (0.52) | PABPC1ALDH1A1HPGDKDM4EHSD17B10 | |
| SCHEMBL10421497 | 0.74 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL1147227 | 0.74 | ALDH1A1 (0.55) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL2317725 | 0.74 | ALDH1A1 (0.59) | ALDH1A1HPGDKDM4EMAPTHSD17B10 | |
| SCHEMBL15453251 | 0.74 | PABPC1 (0.52) | PABPC1ALDH1A1KDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785465-B | Multi-responsiveness polarized light pigment particle and preparation method and application thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-08-18 | — | — | CN | claimed |
| CN-115785465-A | Multi-response polarized light pigment particle and preparation method and application thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-03-14 | — | — | CN | claimed |
| CN-107286038-B | (2- ethoxy) the pyrene formamide of N, N- bis- and its synthetic method and application | 华南师范大学 | 2019-04-30 | — | — | CN | claimed |
| CN-107286038-A | N, N bis-（2 ethoxys）Pyrene formamide and its synthetic method and application | 华南师范大学 | 2017-10-24 | — | — | CN | claimed |
| CN-115785465-B | Multi-responsiveness polarized light pigment particle and preparation method and application thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-08-18 | — | — | CN | disclosed |
| CN-115785465-A | Multi-response polarized light pigment particle and preparation method and application thereof | 现代纺织技术创新中心(鉴湖实验室) | 2023-03-14 | — | — | CN | disclosed |
| CN-107286038-B | (2- ethoxy) the pyrene formamide of N, N- bis- and its synthetic method and application | 华南师范大学 | 2019-04-30 | — | — | CN | disclosed |
| CN-107286038-B | (2- ethoxy) the pyrene formamide of N, N- bis- and its synthetic method and application | 华南师范大学 | 2019-04-30 | — | — | CN | disclosed |
| CN-107286038-B | (2- ethoxy) the pyrene formamide of N, N- bis- and its synthetic method and application | 华南师范大学 | 2019-04-30 | — | — | CN | disclosed |
| CN-108026574-A | Method for analyzing template nucleic acid, method for analyzing target substance, kit for analyzing template nucleic acid or target substance, and device for analyzing template nucleic acid or target substance | 达纳福股份有限公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-107286038-A | N, N bis-（2 ethoxys）Pyrene formamide and its synthetic method and application | 华南师范大学 | 2017-10-24 | — | — | CN | disclosed |
| CN-107286038-A | N, N bis-（2 ethoxys）Pyrene formamide and its synthetic method and application | 华南师范大学 | 2017-10-24 | — | — | CN | disclosed |
| US-7557127-B2 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| US-20090054464-A1 | HDAC INHIBITOR | ASTELLAS PHARMA INC. (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-2025733-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ORGANIC ELECTROLUMINESCENCE ELEMENT | TOYO INK MFG. CO., LTD. (JP) | 2009-02-18 | — | — | EP | disclosed |
| US-7465731-B2 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2008-12-16 | — | — | US | disclosed |
| EP-1776357-A1 | HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) | Astellas Pharma Inc. (JP) | 2007-04-25 | — | — | EP | disclosed |
| US-20060052599-A1 | HDAC inhibitor | ASTELLAS PHARMA INC. (JP) | 2006-03-09 | — | — | US | disclosed |
| WO-2006016680-A1 | HYDROXYAMIDE COMPOUNDS HAVING ACTIVITY AS INHIBITORS OF HISTONE DEACETYLASE (HDAC) | ASTELLAS PHARMA INC. (JP) | 2006-02-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156827-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS AND ORGANIC ELECTROLUMINESCENT ELEMENT | ELP1, ELAVL1, ELF3 | PABPC1 1781/4885ALDH1A1 1089/4885HPGD 4218/4885 |
| US-20060052599-A1 | HDAC inhibitor | HDAC1, HDAC2, HDAC11 | PABPC1 3448/4885ALDH1A1 1014/4885HPGD 2421/4885 |
| US-20090054464-A1 | HDAC INHIBITOR | HDAC1, HDAC2, HDAC8 | PABPC1 2298/4885ALDH1A1 739/4885HPGD 1893/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.